EGFR and neoplasm: In an in situ glioblastoma xenograft mouse model, Yu et al. intracranially injected EGFR-targeting CAR-NK92 cells into mouse brains and found that they effectively inhibited tumor development and significantly improved the survival rate of tumor-bearing mice [341].